Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: experience from an Italian skin cancer unit

Future Oncol. 2021 Mar;17(7):759-761. doi: 10.2217/fon-2020-0997. Epub 2021 Feb 3.
No abstract available

Keywords: COVID-19; advanced metastatic melanoma; targeted therapies.

Publication types

  • Editorial

MeSH terms

  • COVID-19 / epidemiology*
  • Humans
  • MAP Kinase Signaling System / physiology
  • Melanoma / drug therapy*
  • Melanoma / secondary
  • Mitogen-Activated Protein Kinase Kinases / antagonists & inhibitors*
  • Molecular Targeted Therapy
  • Proto-Oncogene Proteins B-raf / antagonists & inhibitors*
  • SARS-CoV-2*
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology

Substances

  • Proto-Oncogene Proteins B-raf
  • Mitogen-Activated Protein Kinase Kinases